萬達電影(002739.SZ):互愛互動將陸續爲國內及海外玩家帶來《變形金剛》等根據頭部電影、動漫、網文及街機遊戲IP改編的精品遊戲作品
格隆匯6月23日丨萬達電影(002739.SZ)在投資者互動平臺表示,近年來,公司旗下互愛互動以“跨界塑造超級IP,進軍全球市場”爲戰略發展方向,打造了25款長期運營、流水穩定的遊戲產品,同時積極拓展海外業務,2024年營業收入同比增幅超50%,其中海外發行收入同比增長197%。2025年,互愛互動將陸續爲國內及海外玩家帶來《變形金剛》《喬喬的奇妙冒險》《全職法師》《我爲歌狂旋律重啓》《SPINE》《彩京》等根據頭部電影、動漫、網文及街機遊戲IP改編的精品遊戲作品,覆蓋不同年齡層玩家的需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.